“Not Today”: Overcoming PrEP Hesitancy, Stigma, and Adherence Barriers With Lenacapavir

Margaret Conrad; Meredith Clement

doi:10.31486/toj.25.5057

Article Information

vol. 25 no. 3 159-161

DOI

https://doi.org/10.31486/toj.25.5057

Published By

Ochsner Journal

Print ISSN

1524-5012

Online ISSN

1524-5012

History

Published online September 23, 2025.

©2025 by the author(s); Creative Commons Attribution License (CC BY) ©2025 by the author(s); licensee Ochsner Journal, Ochsner Clinic Foundation, New Orleans, LA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (creativecommons.org/licenses/by/4.0/legalcode) that permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Author Information

Margaret Conrad, MD¹ and
Meredith Clement, MD²

¹Department of Internal Medicine, Emory School of Medicine, Atlanta, GA
²Section of Infectious Diseases, Louisiana State University Health Sciences Center, New Orleans, LA